Malave Luis (CIK 1395781) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-07). Recent activity: Buy GCTK (1,200 shares), Buy GCTK (463 shares), Buy GCTK (35 shares), Buy GCTK (362 shares), Buy GCTK (8 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-07 | Glucotrack, Inc. (GCTK) | Director | Buy | 1,200 | $0 |
| 2025-10-07 | Glucotrack, Inc. (GCTK) | Director | Buy | 463 | $0 |
| 2025-10-07 | Glucotrack, Inc. (GCTK) | Director | Buy | 35 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 362 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 8 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 11 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 25 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 34 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 44 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 29 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 121 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 489 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 6,886 | $214,843 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 133,532 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 2,076 | $0 |
Source: SEC Form 4 filings · as of 2025-10-07